Gilead Sciences, Inc. (GILD) Shareholders & Insider Trades
Gilead Sciences shareholders at a glance
The largest holder of Gilead Sciences stock is BlackRock Advisors LLC, with 87.9 million shares (7.09% of the company), worth about $12.87 billion as of September 25, 2026. The 10 largest holders together own 40.7%.
In Q2 2026, 2,392 institutional holdings reports listed shares worth $144.00 billion.
Insiders reported 132 transactions in the last two years: 59 sales worth $91.46 million and no purchases. The newest one on file is from September 22, 2026 (Burkhart Erin, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 22, 2026.
Gilead Sciences, Inc.
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Gilead Sciences shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 87.9 million | 7.09% | $12.9B |
| Vanguard Capital Management LLC | 81.1 million | 6.54% | $11.9B |
| Fidelity Management & Research Co. LLC | 66.8 million | 5.39% | $9.8B |
| State Street Corporation | 61.2 million | 4.94% | $9.0B |
| Capital Research & Management Co. (World Investors) | 41.0 million | 3.31% | $6.0B |
| Invesco Advisers, Inc. | 39.8 million | 3.21% | $5.8B |
| Vanguard Portfolio Management LLC | 35.3 million | 2.85% | $5.2B |
| Ishares (DE) InvAG mit Teilgesellschaftsvermogen | 31.3 million | 2.52% | $4.6B |
| Geode Capital Management LLC | 30.1 million | 2.42% | $4.4B |
| T. Rowe Price International Ltd. | 30.0 million | 2.42% | $4.4B |
As of September 25, 2026.
Gilead Sciences institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,392 | – | $144.0B |
| Q1 2026 | 2,434 | 1.09 billion | $152.0B |
| Q4 2025 | 2,330 | 1.12 billion | $138.0B |
| Q3 2025 | 2,151 | 1.08 billion | $120.0B |
| Q2 2025 | 2,133 | 1.08 billion | $120.0B |
| Q1 2025 | 2,123 | 1.07 billion | $120.0B |
| Q4 2024 | 1,989 | 1.07 billion | $98.4B |
| Q3 2024 | 1,826 | 1.06 billion | $88.8B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Gilead Sciences insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Burkhart Erin | Sep 22, 2026 | Officer | -- | – |
| Dickinson Andrew D | Sep 15, 2026 | Chief Financial Officer | Sale at price 145.29 per share. | $435,870 |
| Mercier Johanna | Sep 15, 2026 | Officer | Sale at price 143.69 - 145.29 per share. | $432,646 |
| Cain Wettan Keeley M | Sep 10, 2026 | General Counsel | -- | – |
| O'Day Daniel Patrick | Sep 10, 2026 | Chief Executive Officer | -- | – |
| Berger Dietmar P. | Sep 10, 2026 | Officer | -- | – |
| Mercier Johanna | Sep 10, 2026 | Officer | -- | – |
| Dickinson Andrew D | Sep 10, 2026 | Chief Financial Officer | -- | – |
| O'Day Daniel Patrick | Sep 1, 2026 | Chief Executive Officer | Sale at price 147.51 - 149.38 per share. | $2.2M |
| Welters Anthony | Aug 26, 2026 | Director | Sale at price 148.24 - 148.82 per share. | $2.7M |
| Welters Anthony | Aug 26, 2026 | Director | Conversion of Exercise of derivative security at price 60.67 - 61.35 per share. | $1.1M |
| Bluestone Jeffrey | Aug 20, 2026 | Director | Conversion of Exercise of derivative security at price 61.35 - 67.45 per share. | $335,206 |
Newest 12 of 132 insider transactions in the last two years.
Questions and answers
Who owns the most Gilead Sciences stock?
BlackRock Advisors LLC, with 7.09% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.54%) and Fidelity Management & Research Co. LLC (5.39%).
How many institutions own Gilead Sciences stock?
2,392 institutional holdings reports listed Gilead Sciences shares in Q2 2026 worth $144.00 billion.
Are Gilead Sciences insiders buying or selling the stock?
In the last two years insiders reported 59 sales and no purchases (132 transactions in all); the newest on file is from September 22, 2026.
